Trials / Completed
CompletedNCT00792714
Pharmacokinetics of Inhaled Mannitol in Cystic Fibrosis Patients
Determination of the Pharmacokinetics of Inhaled Mannitol After Single and Multiple Dosing in Cystic Fibrosis Patients
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 18 (estimated)
- Sponsor
- Syntara · Industry
- Sex
- All
- Age
- 6 Years
- Healthy volunteers
- Not accepted
Summary
The general objective of the study is to estimate the systemic pharmacokinetics of mannitol after single and multiple dosing of IDPM 400 mg to adult and paediatric cystic fibrosis patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Mannitol | 400mg twice daily for 7 days |
Timeline
- Start date
- 2008-12-01
- Primary completion
- 2009-09-01
- Completion
- 2009-09-01
- First posted
- 2008-11-18
- Last updated
- 2010-02-02
Locations
4 sites across 2 countries: Australia, United Kingdom
Source: ClinicalTrials.gov record NCT00792714. Inclusion in this directory is not an endorsement.